Analyst worked in AMT, AMV section having exposure to HPLC, GC, IC, AAS. Analyst worked in GLP Section having exposure instrument calibration, Qualification, Standard Management, Working Standard qualification.
The findings, published today in Nature Medicine, show that these genetic factors also lead to quicker development of health complications, earlier need for insulin treatment, and a weaker response to some medications. The results of this research, funded by Barts Charity and Wellcome, reinforce the need to understand how genetic variation across different population groups can influence the onset of diseases, treatment responses, and disease progression.
Toripalimab is a New Biological Entity. It is the only immuno-oncology drug approved by various regulatory authorities around the world such as the United States Food and Drug Administration, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, and others for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma.
Abbott, the global healthcare leader, announced today the launch of its Pneumococcal Conjugate Vaccine, PneumoShield 14, for children over 6 weeks of age. Abbott’s PCV-14 valent (Pneumococcal Conjugate Vaccine), offers broad protection, covering the highest number of serotypes, or strains, as compared to existing PCV-10 and PCV-13 vaccines.
Post Graduate degree in any of the subjects viz- Biochemistry or Chemistry or Microbiology or Molecular biology or Pharmacology or Pharmacy or Toxicology or Virology or Zoology or Biotechnology or Botany or Bio-Informatics or Biostatistics with eight years Research and Development or Teaching or working experience from public sector or Government recognized institutions.
MPhil in Neurophysiology, Neurosciences OR Masters Degree in Neurosciences, Physiology, Life Sciences, M.S Pharm or M. Pharm. in Pharmacology or Biotechnology or equivalent Master’s degree with good academic record
BPharm, BVSc, BSc or equivalent degree and one publication in SCI Journal and should have completed at least three years of research experience as on the last date of application, evidenced from fellowship, associateship or from date of registration for Ph.D.
1st class masters degree in microbiology, medical microbiology, life sciences, zoology, biostatistics, biotechnology, genetics, or biochemistry or related subject from a recognized university AND 4 years experience.
M.Sc., Chemistry, Analytical Chemistry, Inorganic Chemistry from a recognized University, Institution.
Candidates qualified in national level exams such as CSIR-JRF, NET, GATE will be preferred.
Masters degree in Natural Sciences or Agricultural Sciences, MVSc or Bachelors degree in Engineering or Technology or Medicine from a recognized University or equivalent with minimum 60% marks.
Skilled in process validation document preparation and review, with strong knowledge of QMS, qualification documents, regulatory audits, and vendor qualification and audits in a regulated environment.
Alembic Pharmaceuticals Limited's rich legacy spanning over a century in the Indian Pharma Industry. With a steadfast commitment to quality and innovation, we continue to make significant strides in the pharmaceutical sector.
Otsuka Pharmaceutical India Private Limited primarily manufacturing IV and parenteral nutrition products across multiple markets and therapeutic segments.
Supervising and leading a team of operators and technicians to ensure efficient and compliant production of injectable medications. This includes assigning tasks, providing guidance, and monitoring performance to achieve production targets and maintain quality standards.